Invention Grant
- Patent Title: Crystalline forms of an NK-1 antagonist
-
Application No.: US16259913Application Date: 2019-01-28
-
Publication No.: US10676440B2Publication Date: 2020-06-09
- Inventor: Christian Bacilieri , Gionata Frasca
- Applicant: Helsinn Healthcare SA
- Applicant Address: CH Lugano/Pazzallo
- Assignee: Helsinn Healthcare SA
- Current Assignee: Helsinn Healthcare SA
- Current Assignee Address: CH Lugano/Pazzallo
- Agent Clark G. Sullivan
- Main IPC: C07D213/75
- IPC: C07D213/75
Abstract:
The present invention is related to crystalline forms of 2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethyl-N-(6-(4-methylpiperazin-1-yl)-4-(o-tolyl)pyridin-3-yl)propanamide which is an NK-1 antagonist useful in the treatment of induced vomiting and other disorders.
Public/Granted literature
- US20190152915A1 CRYSTALLINE FORMS OF AN NK-1 ANTAGONIST Public/Granted day:2019-05-23
Information query
IPC分类:
